Study Evaluating The Safety And Efficacy Of Desvenlafaxine Succinate For Vasomotor Symptoms In Menopausal Women
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy and safety of Desvenlafaxine Succinate
(DVS) Sustained Release (SR), in comparison to placebo for the treatment of Vasomotor
Symptoms (VMS) in menopausal women.